NCT01164332View on ClinicalTrials.gov

Sensitivity of Alternative NRL972 Detection Methods in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2011

Conditions

Cirrhosis

Interventions

OTHER

NRL972

Two-hour intravenous infusion of 5 and 15 mg per hour

Trial Locations (1)

H-8230

Phase I-II study clinical of the Drug Research Center Ltd., Balatonfüred

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Norgine

INDUSTRY